These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study. Yao Z; Wang L; Lu Q; Liu H; Teng G J Affect Disord; 2009 Jun; 115(3):430-8. PubMed ID: 19007997 [TBL] [Abstract][Full Text] [Related]
26. Chronic depression: future prospects from recent research. Ferrier IN Int Clin Psychopharmacol; 1991 Jul; 6 Suppl 1():83-9. PubMed ID: 1684591 [TBL] [Abstract][Full Text] [Related]
28. Depression and the role of genes involved in dopamine metabolism and signalling. Opmeer EM; Kortekaas R; Aleman A Prog Neurobiol; 2010 Oct; 92(2):112-33. PubMed ID: 20558238 [TBL] [Abstract][Full Text] [Related]
30. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. Rigucci S; Serafini G; Pompili M; Kotzalidis GD; Tatarelli R World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):165-80. PubMed ID: 19670087 [TBL] [Abstract][Full Text] [Related]
31. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. Trivedi MH; Lin EH; Katon WJ CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951 [TBL] [Abstract][Full Text] [Related]
32. The developmental association between eating disorders symptoms and symptoms of depression and anxiety in juvenile twin girls. Silberg JL; Bulik CM J Child Psychol Psychiatry; 2005 Dec; 46(12):1317-26. PubMed ID: 16313432 [TBL] [Abstract][Full Text] [Related]
33. Brain, networks, depression, and more. Leistedt SJ; Linkowski P Eur Neuropsychopharmacol; 2013 Jan; 23(1):55-62. PubMed ID: 23154052 [TBL] [Abstract][Full Text] [Related]
34. Treat the brain and treat the periphery: toward a holistic approach to major depressive disorder. Zheng X; Zhang X; Wang G; Hao H Drug Discov Today; 2015 May; 20(5):562-8. PubMed ID: 25849660 [TBL] [Abstract][Full Text] [Related]
35. Shared genetic contributions to pathological gambling and major depression in men. Potenza MN; Xian H; Shah K; Scherrer JF; Eisen SA Arch Gen Psychiatry; 2005 Sep; 62(9):1015-21. PubMed ID: 16143733 [TBL] [Abstract][Full Text] [Related]
36. Conversion disorder revisited. Ballmaier M; Schmidt R Funct Neurol; 2005; 20(3):105-13. PubMed ID: 16324233 [TBL] [Abstract][Full Text] [Related]
37. The economic impact of depression: resistance or severity? Fostick L; Silberman A; Beckman M; Spivak B; Amital D Eur Neuropsychopharmacol; 2010 Oct; 20(10):671-5. PubMed ID: 20624674 [TBL] [Abstract][Full Text] [Related]
38. DNA Methylation in Major Depressive Disorder. Pishva E; Rutten BPF; van den Hove D Adv Exp Med Biol; 2017; 978():185-196. PubMed ID: 28523547 [TBL] [Abstract][Full Text] [Related]
39. 5-HT1A receptors, gene repression, and depression: guilt by association. Albert PR; Lemonde S Neuroscientist; 2004 Dec; 10(6):575-93. PubMed ID: 15534042 [TBL] [Abstract][Full Text] [Related]
40. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population. Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]